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Summary
The syntheses of 2,6-bis[4-(4,5-dihydro-1H-imidazol-2-yl)phenyl]pyridine 7, 2-[4-(4,5-
dihydro-1H-imidazol-2-yl)-phenyl]-6-[3-(4,5-dihydro-1H-imidazol-2-yl)phenyl]pyridine 8 and
2,6-bis[3-(4,5-dihydro-1H-imidazol-2-yl)phenyl]pyridine 9 in five steps from the appropriately
substituted bromoacetophenone are described. 3,5-Bis[4-(4,5-dihydro-1H-imidazol-2-
yl)phenyl]pyridine 13 is also reported, prepared in four steps from 4-bromophenylacetonitrile. The
preparation of 2,5-bis[4-(4,5-dihydro-1H-imidazol-2-yl)-phenyl]pyridine 18 from 4-
bromoacetophenone in six steps is presented. The dications bind to poly dA·dT in the order 7 > 13
> 18 > 8 > 9; the order of binding to poly A·U is 7 > 13 > 8 > 9; 18 essentially does not bind to the
RNA model. Only 7 inhibits topoisomerase II at millimolar concentrations. The dicationic
compounds that were tested against Pneumonocystis carinii in the immuno-suppressed rat model
show only modest activity and are moderately toxic. Some of the compounds demonstrated
modest anti-HIV-1 activity and selectivity in primary lymphocytes.
Keywords
pyridine; diaryldiamidine; DNA; RNA; topoisomerase II; HIV; PCP
Introduction
For a number of years, studies from our laboratories have examined the structural factors
that influence the interaction of dicationic diaryldiamidines with nucleic acids [1-3] and the
relationship between such interactions and the biological properties of diamidines [4]. The
precise mode of binding of these types of dicationic molecules with DNA has been found to
be extremely sensitive to structure and dramatic differences in binding mode and specificity
have resulted from relatively minor changes in structure. The aromatic diamidines berenil
and stilbamidine exhibit strong minor groove binding at sites which have three or more
consecutive AT base pairs [5,6]. However, the well-known DNA stain DAPI, 2-[4'-
guanylphenyl]-6-guanylindole, which has long been known to bind in the minor groove of
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DNA at AT sites, has also been found to intercalate at GC sites [2]. In a related study, the
nucleic-acid binding properties of a series of 2,5-diphenylfuran dications were found to vary
in interaction with DNA from AT-selective minor groove binding to classical intercalation
at GC sites and threading intercalation at GC sites, depending upon the intrinsic nature of
the cationic groups [3]. A series of dications with six-membered ring nitrogen heterocycles
as spacers between benzamidino groups has been found to bind to the minor groove of AT-
rich regions of DNA and intercalate at GC sites [7]. Recently, the radius of curvature of
groove-binding molecules has been demonstrated to be an important factor in determining
the effectiveness of interaction of groove-binding dications with DNA [8]. In addition,
certain diamidines, for example DAPI, several dicationic 2,5-diarylfurans and dicationic
triazines, have been found to bind strongly to RNA [9].
We recently reported the synthesis and biological evaluation of a diaryl triazines which bind
to nucleic acids [10]. In this article, we describe the synthesis of three sets of isomeric
diarylpyridines, 2,6-diaryl-, 3,5-diaryl- and 2,5-diarylpyridines which have different intrinsic
geometric relationships between the dicationic groups and therefore different radius of
curvature values.
Chemistry
For the 2,6-diarylpyridine series, three different systems were selected for synthesis, which
place the cationic centers of the molecules at different relative locations (see scheme 1).
Each of these three 2,6-diarylpyridine systems were synthesized in a similar fashion starting
from the appropriate bromo-substituted acetophenones. The approaches used, which are
based on the Krohnke 2,6-diarylpyridine synthesis [11], are summarized in scheme 1 and
lead to the three different 2,6-bis-[bromophenyl]pyridines (1-3). The various 2,6-bis-
[bromophenyl]pyridines were allowed to react with copper(I) cyanide in refluxing
dimethylformamide, which typically gave the corresponding bis-nitriles 4-6 in reasonable
yields. As a result of the treatment of the bis-nitriles with ammonium hydroxide to remove
copper ions during isolation, the product was often contaminated with low percentages of
amide as indicated by infrared spectroscopy. Dehydration of the amide by treatment of the
amide/nitrile mixtures with trifluoroacetic anhydride/pyridine [12] yielded amide-free
bisnitriles. Efforts to prepare bis-amidines from the bisnitriles by the imidate ester route
resulted, in our hands, in mixtures of amide and amidines which we were unable to separate.
This problem was circumvented by preparation of cyclic amidines 7-9 by direct fusion of the
bis-nitriles with the ethylenediamine hydrochloride [10,13].
Direct methods for synthesis of bis-3,5-diarylpyridines are limited. Routes involving
palladium-catalyzed coupling [14] were considered but the method of Ohshiro [15] as
outlined in scheme 2, worked satisfactorily. Reduction of 4-bromophenylacetonitrile with
DIBAL yielded the corresponding 4-bromophenylacetaldehyde, which was not isolated but
was directly converted into the enamine 10 by reaction with morpholine [16]. The
remarkable reaction of the enamine 10 with 1,3,5-tri-t-butylhexahydra-1,3,5-triazine in p-
xylene gave an approximately 60% yield of 3,5-bis[4'-bromophenyl]pyridine 11.
Apparently, on refiuxing in p-xylene, 1,3,5-tri-t-butylhexahydra-1,3,5-triazine serves as an
in situ source of N-t-butylmethanimine or the equivalent [15]. The bis-bromophenylpyridine
11 was converted into the bis-nitrile 12 and ultimately into the bisimidiazoline compound 13
by the approach previously described for the 2,6-diarylpyridine series.
Synthetic methods for preparation of bis-2,5-diarylpyridines are also limited. In this case
also, palladium-catalyzed coupling approaches were not chosen. The unusual method of
Chalk [17] (scheme 3) was successfully employed. This approach requires a 1,4-diaryl-1,3-
butadiyne, which was made starting with a conventional approach involving the reaction of
Kumar et al. Page 2













phosphorus pentachloride with 4-bromoacetophenone to yield a mixture of chloro
compounds, 1,1-dichloro-1-( 4'-bromophenyl)ethane and α-chloro-4'-bromostyrene. On
dehydrohalogenation the mixture gave 4-bromophenylethyne 14 [18]. Oxidative coupling of
the arylethyne yielded 1,4-bis[4'-bromophenyl]-1,3-butadiyne 15 [19]. The 1,3-butadiyne 15
undergoes reaction with phenylethylamine in a remarkable process [17], in which, in effect,
phenylethylamine serves as a source for methanimine or the equivalent, to yield 2,5-[4'-
bromophenyl]pyridine 16 in approximately 30% yield. 2,5-Bis[bromophenyl]-pyridine 16
was converted into the bis-nitrile derivative 17, which was transformed into the
corresponding bis-imidazoline compound 18 following procedures developed for the
synthesis of both series of diarylpyridines previously described.
A monocationic 2,6-diarylpyridine was needed as a control compound for nucleic-acid
binding studies. Consequently, 2-phenyl-6-[4-(4,5-dihydro-1H-2-
ylimidazolyl)phenyl]pyridine 19 was prepared using the same approach employed for the
synthesis of 7.
Biological results and discussion
The results from various biological evaluations of the diarylpyridines are presented in table
I. The binding of the dicationic pyridines with DNA and RNA was evaluated by measuring
the increase in thermal melting temperature (ΔTm) on complex formation with poly dA·dT
and poly A·U, respectively [9]. Compounds 7 and 13 have the radius of curvature values that
are the most favorable for complementing the minor groove and their ΔTm values on binding
to poly dA·dT are the largest (24 and 22.8). The somewhat smaller ΔTm value for 13 is
consistent with the fact that the 4-proton of 13 is likely to interfere with a tight fit in the
minor groove on complex formation as well as produce a twist in the benzamidine ring
pyridine ring bond. The compounds 8 and 9 have cationic centers located at the meta
positions of the benzamidine rings consequently resulting in a more acute radius of
curvature. A similar result was noted by Cory et al for some meta-substituted pentamidine
analogs [8]. Interestingly, the more linear molecule 18, with a large radius of curvature,
binds relatively strongly to DNA suggesting that the minor groove is more accommodating
to approximately linear molecules than to acutely curved ones. Intercalation of 18 with DNA
cannot be excluded on the basis of the current data. Since the intercalation sites on both
DNA and RNA are quite similar [20] and since 18 essentially does not bind to RNA (vide
infra), it seems unlikely that 18 intercalates with DNA.
The binding to RNA by diaryl dications related to those under investigation here is thought
to be by intercalation [9]. The 2,6-diarylpyridine 7 exhibits the largest ΔTm value on binding
to RNA of this series of dicationic pyridines. Molecular modeling suggests a good fit in the
RNA intercalation cavity for molecules of this shape [20]. The 3,5-diaryl pyridine analog 13
is of similar shape to that of 7, but the van-der-Waals interactions between the 4-proton on
the pyridine ring and the ortho-protons on the benzamidine rings cause a torsion angle twist
which would reduce favorable stacking interactions and is presumably reflected in the lower
ΔTm value. The two compounds with meta cationic centers 8 and 9 give only modest ΔTm
values, which apparently reflects the overall poorer fit of these shaped molecules in the
RNA intercalation site. The approximately linear molecule 18, again shows different
properties, but it essentially does not bind to RNA. Presumably, the way this molecule
interacts with RNA is in a bayonet insertion manner which would provide very poor
stacking interactions and the cationic centers would be well away from the backbone
phosphate groups.
In view of the moderately strong RNA interactions of some of the dicationic pyridines, the
compounds were evaluated against HIV-1 in a previously described cell culture screen [21].
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Significant anti-HIY activity was noted for 7, the compound with the highest RNA affinity.
Cell toxicity was apparent for the dicationic pyridines tested, although some of the
compounds had a therapeutic index of greater than 10, suggesting that these compounds are
modest selective inhibitors of HIV.
Other diaryl diamidines have been found to inhibit microbial topoisomerases [22,23] and
consequently the pyridines were evaluated against topoisomerase II from Giardia lamblia
and Pneumonocystis carinii (see table I). Moderate inhibition of these enzymes was noted,
however, only 7 was active at micromolar concentrations against topoisomerase II from P
carinii. Several of the dicationic pyridines were evaluated against P carinii pneumonia in
the immunosuppressed rat model [24]. The pyridines tested were only modestly effective at
5 mg/kg dosage and most showed moderate toxicity.
Experimental protocols
2,6-Bis[4-bromophenyl]pyridine 1
α-[N-Pyridinium]-4'-bromoacetophenone bromide [28] (14.28 g, 0.04 mol), β-[[N,N-
dimethylamino]-4'-bromopropiophenone hydrochloride [29] (11.7 g, 0.04 mol), ammonium
acetate (30.8 g, 0.5 mol) in a mixture of 60 ml glacial acetic acid and 15 ml acetic anhydride
were heated at reflux for 2 h. The reaction mixture was cooled and 200 ml cold water were
added; the resulting brown precipitate was collected by filtration, washed with water and
dried. The solid was washed with 50 ml ethanol/ether (1:1) to yield 8.7 g (56%) of an off-
white solid, mp 180–181°C. IR (KBr) (cm-1) 1560, 1519, 1449, 780. 1H-NMR (DMSO-
d6/90°C) (ppm, J values in Hz) 8.08 (d, 4H, J = 8.79), 7 94–7.82 (m, 3H), 7.65 (d, 4H, J =
8.79). 13C-NMR (DMSO-d6/90°C) (ppm) 154.3, 137.7, 137.39, 131.03, 128.04, 122.2,
118.42. MS m/e 389 (M+).
2-[4-Bromophenyl]-6-[3-bromophenyl]pyridine 2
α-[N-Pyridinium]-4-bromoacetophenone bromide [28] and β-[N,N-dimethylamino]-3-
bromopropiophenone hydrochloride [30] were allowed to react as described above for 1 to
give 9.3 g (60%) yield of 2, mp 68–69°C. IR (KBr) (cm–1) 1559, 1450, 769. 1H-NMR
(DMSO-d6/35°C) (ppm, J values in Hz) 8.34 (dd, 1H, J = 1.46, J = 1.96), 8.16 (dd, 1H, J =
1.46, J = 1.96, J = 8.3), 8.12 (dd, 2H, J = 1.95, J = 8.79), 7.94–7.97 (m, 3H), 7.68 (dd, 2H, J
= 1.95, J = 8.79), 7.62 (td, 1H, J = 1.46. J = 1.96, J = 8.3), 7.46 (dd, 1H, J = 7.8, J =
8.3). 13C (DMSO-d6/35°C) (ppm) 154.5, 154.0, 140.7, 138.5, 137.5, 131.8, 131.6, l30.8,
129.0, 128.5, 125.5, 122.8, 122.2, 119.4, 119.3, MS m/e 389 (M+).
2,6-Bis[3-hromophenyl]pyridine 3
α-[N-Pyridinium]-3'-bromoacetophenone bromide [31,32] and β-[N,N-dimethylamino]-3'-
bromopropiophenone hydrochloride [30] were allowed to react as described above for 1.
The oily mass that separated was chromatographed over neutral Al2O3, using benzene/
EtOAc (95:5) to give a yield of 7.9 g (50%) of 3, mp 36–37°C. IR (KBr) (cm–1) 1569, 1462,
1185, 1069, 797, 763. 1H-NMR (DMSO/45°C) (ppm, J values in Hz) 8.31 (s. 2H), 8.14 (d,
2H, J = 7.81), 8.02–7.84 (m, 3H), 7.62 (d, 2H, J = 7.81), 7.45 (t, 2H, J = 7.82). 13C-NMR
(DMSO-d6/45°C) (ppm) 154.0, 140.7, 138.5, 131.8, 130.8, 129.0, 125.5, 122.2, 119.7. MS
m/e 389 (M+).
3,5-Bis(4-bromophenyl)pyridine 11
To a mechanically stirred solution 24.8 g (0.13 mol) of 4-bromophenylacetonitrile in 100 ml
dry toluene under nitrogen, a mixture of 162 ml 1 M DIBAL and 30 ml toluene was added
dropwise, during which time the temperature was maintained below –5°C. After addition of
DIBAL was complete (ca 1 h), the reaction mixture was stirred for an additional 1.5 h at –
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5°C. To the stirred solution, ethanol (50 ml) was added dropwise while maintaining the
temperature below –5°C. While continuing to stir, 300 ml of 1 M H2SO4 was added slowly
to the reaction mixture during which time the temperature was maintained between 0 and
5°C. The mixture was allowed to slowly warm to room temperature during which time the
product appeared as a gummy solid which adhered to the flask. Toluene (100 ml) was added
after stirring, the phases were separated and the organic layer was washed with a saturated
sodium chloride solution (2 × 100 ml). The toluene solution (yellow) was added to 50 ml
morpholine with stirring. After ca 10 min, the color changed to red and the reaction mixture
was allowed to stand overnight. The solvent and excess morpholine were removed under
reduced pressure and the residue was dissolved in cyclohexane. After concentration, 15 g
(43%) of crude solid (mp 120–132°) was collected by filtration. Recrystallization from
ethanol yielded 7.8 g (23%, mp 130–135°C) of 2-[N-morpholino]-4'-bromostyrene (10) [16].
To a 37% formaldehyde solution (135 ml) was added drop-wise 96 ml of t-butylamine
during which time the temperature was maintained near 5°C [33]. After the addition was
complete, the mixture was allowed to slowly warm to room temperature and the mixture was
stirred for 2 h. The organic layer was separated and allowed to stand over solid KOH for 3 h
and decanted and was placed over fresh solid KOH. The process was repeated 5 times and
ultimately 45 g (58%) of liquid hexahydra-1,3,5-tri-t-butyl-1,3.5-triazine was obtained,
which was used without further purification in the next step.
A mixture of 10 (7.6 g, 0.028 mol) and 1,3,5-tri-t-butyl-hexahydra-1,3,5-triazine (1.18 g,
0.014 mol) in 100 ml p-xylene was allowed to reflux under nitrogen for 70 h (moni tored by
TLC) [15]. The solvent was removed under reduced pressure and the residue was
recrystallized from approximately boiling ethanol to yield 3.5 g (66%), mp 213–215°C, of
11. IR (KBr) (cm–1), 1468, 1381, 824. 1H-NMR (DMSO-d6) (ppm, J values in Hz) 8.88 (d,
2H, J = 1.95), 8.3 (dd, 1H, J = 2.44, J = 1.95), 7.8 (d, 4H, J = 8.79), 7.7 (d, 4H, J =
8.79). 13C-NMR (DMSO-d6) (ppm) 146.1, 135.6, 134.1, 131.3, 128.6, 121.3. MS m/e 389
(M+).
2,5-Bis(4-bromophenyl)pyridine 16
Phosphorus pentachloride (228.5 g, 1.1 mol) was added to well-stirred 4-
bromoacetophenone (190 g, 0.95 mol). The mixture was slowly warmed and the reaction
became vigorous and HCl evolved. The mixture was stirred at 70°C for 1.5 h and distilled
under reduced pressure. The fraction that boiled between 123–127°C/18 mm Hg was
collected (130 g). This fraction was a mixture of α-chloro-4'-bromostyrene and 1,1-
dichloro-1-[4-bromophenyl]ethane and it was directly dehydrohalogenated [17].
To a well-stirred mixture of the above chloro compounds (105 g), 500 ml of 25% KOH in
ethanol was slowly added; external cooling was employed to maintain the temperature under
40°C. After addition of the ethanolic potassium hydroxide was complete, the mixture was
heated at reflux for 4 h. A large amount of salt separated and it was removed by hot
filtration. The solid was washed with ether and the combined organic phases were
evaporated under reduced pressure. The residue was dissolved in ether. The ether was
washed with HCl solution to neutralize any remaining base. The ether layer was washed
with brine, dried over anhydrous sodium sulfate and then removed in vacuo. The remaining
oil was distilled 118–120°C/18 mm Hg and the distillate crystallized on cooling to give 14,
mp 63–64°C (40 g, 40%); lit mp 64–65°C [18].
A solution of 4-bromophenylethyne (14) (31.9 g, 0.176 mol) in 50 ml ethanol was added to a
stirred slurry of copper(II) acetate dihydrate (49.5 g, 0.232 mol) in 180 ml of pyridine/
methanol (1:1). Additional pyridine/methanol (150 ml:30 ml) was added to facilitate stirring
and the mixture was allowed to reflux for 2 h. The reaction mixture was cooled and carefully
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added to 550 ml conc H2SO4 with external cooling and stirring. The resulting solid was
collected by filtration. The solid was slurried in 75 ml of ethanol/water (50:50) and 40 g of
silver nitrate in 75 ml of ethanol/water (50:50) was added. The mixture was stirred at room
temperature for 0.5 h and filtered. The solid was washed with water, dried and placed in a
Soxlet device and extracted with benzene (24 h). Evaporation of benzene gave 24.1 g (76%)
of off-white solid 15 which melted at 260°C (lit value [33] 260°C).
A mixture of 14.4 g (0.04 mol) of 1,4-bis[4-bromophenyl]-1,3-butadiyne (15) and 35 ml
phenylethylamine were heated at 145°C for 13 h (nitrogen atmosphere). After cooling,
benzene (500 ml) was added. The benzene solution was washed with 10% acetic acid (3 ×
200 ml), 5% sodium hydroxide (2 × 200 ml) and water (3 × 100 ml). The organic phase was
dried (MgSO4) and the solvent removed under reduced pressure to yield a red oil which on
trituration with acetone afforded 16 as pale-yellow crystals 4.5 g (28%), mp 245–247°C. IR
(KBr) (cm–1), 1457, 1064, 814. 1H-NMR (DMSO-d6, 80°C) (ppm, J values in Hz) δ 8.96
1H, d, J = 2.4), 8.15 (1H, dd, J = 2.4, J = 8.3) 8.09 (2H, d, J = 8.8), 8.03 (1H, d, J = 8.3),
7.74 (2H, d, J = 8.8), 7.67 (2H, d, J = 8.8). 13C-NMR (DMSO-d6, 80°C) (ppm) 153.7, 146.8,
137.0, 135.5, 134.3, 132.8, 131.3, 131.0, 128.1, 127.9, 122.1, 121.1, 119.4. MS (m/e) 389.
2,6-Bis[4-cyanophenyl]pyridine 4
A mixture of 2,6-bis[4-bromophenyl]pyridine (1) (7.8 g, 0.02 mol) and copper(I) cyanide
(7.2 g, 0.08 mol) in 75 ml dry DMF was heated at reflux with stirring for 10δ15 h
(monitored by TLC). The hot reaction mixture was poured into a stirred slurry of ice in
water. The resulting yellow-brown solid was filtered, suspended in 300 ml of 10% NH4OH,
stirred for 0.5 h and filtered. The solid was washed repeatedly with water until the washings
were no longer blue. The resultant cream-colored solid was dried in vacuo. Infrared
spectroscopy indicated partial hydrolysis of nitrile to amide. The mixture of solids was
suspended in 40 ml anhydrous THF and 4.5 ml pyridine was added. To this mixture, 5 ml
trifluoroacetic acid anhydride was carefully added (exothermic). The mixture (under
nitrogen) was stirred for 10 h and poured into 10% NaHCO3 slowly with stirring and
cooling. The resultant solid was filtered, washed with water until neutral and dried in vacuo.
The solid was placed in a sox let device and extracted with acetone for 24 h. The resulting
solid obtained after removal of acetone was dissolved in dioxane and passed through a short
(1 inch) column of neutral alumnia; the solid 4 obtained was 3.3 g (58%) mp 234δ235°C. IR
(KBr) (cm–1) 2224, 1602, 1590, 1450, 796. 1H-NMR (DMSO-d6/30°C) (ppm, J values in
Hz) 8.4 (d, 4H, J = 8.3), 8.14δ8.08 (m, 3H), 7.97 (d, 4H, J = 8.3). 13C-NMR (DMSO-
d6/35°C) (ppm) 153.8, 142.2, 138.3, 132.1, 127.0,120.28, 118.04. 111.44. MS (m/e) 281
(M+).
2[4-Cyanophenyl]-6-[3-cyanophenyl]pyridine 5
2[4-Bromophenyl]-6-13-bromophenyl]pyridine (2) was allowed to react with copper(I)
cyanide as described above for 4 to give 3.7 g (65%) of 5, mp 202–203°C. IR (KBr) (cm–1),
2222, 1576, 1445, 800. 1H-NMR DMSO-d6/35°C) (ppm, J values in Hz) 8.61 (dd, 1H, J =
1.46, J = 1.96), 8.52 (td, 1H, J = 1.46, J = 1.96, J = 8.3), 8.4 (dd, 2H, J = 1.95, J = 8.79), 8.1
(m, 3H), 7.96 (dd, 2H, J = 1.95, J = 8.79), 7.92 (td, 1H, J = 1.46, J = 1.96, J = 8.3), 7.72 (t,
1H, J = 7.91). 13C-NMR (DMSO-d6) (ppm) 153.7, 153.6, 142.2, 139.2, 138.5, 132.5, 132.4,
131.1, 130.1, 129.8, 129.7, 127.3, 120.2, 120.1, 118.4. 111.9, 111.6. MS m/e 281 (M+).
2,6-Bis[3-cyanophenyl]pyridine 6
2,6-Bis[3-bromophenyl]pyridine (3) was allowed to react with copper(I) cyanide as
described above for 4 to yield 2.9 g (52%) of 6, mp 176–177°C. IR (KBr) (cm–1) 2227,
1560, 1458, 783. 1H-NMR (DMSO/45°C) (ppm, J values in Hz) 8.63 (t, 2H, J = 1.47), 8.55
(td, 2H, J = 1.47, J = 7.82), 8.08 (m, 3H), 7.92 (td, 2H, J 1.47, J = 7.82), 7.73 (t. 2H, J =
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7.82). 13C-NMR (DMSO-d6/45°C) (ppm) 153.7, 139.4, 138.8, 132.6, 131.2, 130.1, 129.9,
120.1, 118.6, 112.0. MS m/e 281 (M+).
3,5-Bis(4-cyanophenyl)pyridine 12
3,5-Bis(4-bromophenyl)pyridine (11) was allowed to react with copper(I) cyanide as
described above for 4 to yield 3.1 g (55%) mp 294–296°C. IR (KBr) (cm–1) 2225, 1604,
1507, 855. 1H-NMR (DMSO-d6) (ppm, J values in Hz) 9.05 (d, 2H, J = 1.9), 8.48 (dd, 1H, J
= 2.44, J = 1.9), 8.08 (d, 4H, J = 8.3), 7.98 (d, 4H, J = 8.79). 13C-NMR (DMSO-d6) (ppm),
147.8, 141.2, 134.0, 133.0, 132.9, 128.1, 118.6, 111.0. MS m/e 281 (M+).
2,5-Bis(4-cyanophenyl)pyridine 17
2.5-Bis(4-bromophenyl)pyridine (16) was allowed to react with copper(I) cyanide as
described above for 4 to yield 3.0 g (53%) of 17, mp 264–266°C. IR (KBr) (cm–1) 2225,
1573, 1459, 1440, 702, 678. 1H-NMR (DMSO-d6/80°C) (ppm, J values in Hz) 9.09 (d, 1H,
J = 1.95), 8.32 (d, 2H, J = 8.79), 8.3 (dd, 1H, J = 1.95, J = 8.32), 8.17 (d, 1H, J = 8.3), 8.02
(d, 2H, J = 8.79), 7.93 (d, 4H, J = 8.79). 13C-NMR (DMSO-d6/80°C) (ppm) 153.6, 147.5,
141.8, 140.6, 139.3, 135.1, 133.0, 132.3, 132.0, 127.2, 126.8, 120.5, 117.9, 111.4, 110.7. MS
m/e 281 (M+).
2,6-Bis[4-(4,5-dihydro-1H-imidazol-2-yl)phenyl]pyridine 7
The bis-cyano compound 4 (0.56 g, 0.002 mol) was added to molten ethylenediamine
hydrochloride (1.4 g, 0.01 mol) in a 25 ml round-bottomed flask. The mixture was stirred at
300–305°C for 10 min, during which time ammonia was evolved. The crude product was
dissolved in boiling water (ca 25 ml) and filtered hot. The filtrate was concentrated with a
stream of nitrogen to a volume of ca 5 ml and the solid which formed was collected by
filtration. The yellow-brown solid was dissolved in 15 ml water, and the pH was adjusted to
ca 10 by addition of 2 M NaOH with cooling and stirring. The resulting free base 7 was
collected by filtration and recrystallization from hot ethanol yielded 0.33 g (45%) mp >
360°C. Anal calc for: C23H21N5: C, 75.17; H, 5.76; N, 19.06. Found: C, 74.96; H, 5.79; N,
18.97. IR (KBr) (cm–1) 3215, 2930, 2851, 1615, 1615, 1600. 1H-NMR (DMSO-d6, 100°C)
(ppm, J values in Hz) 8.23 (d, 4H, J = 8.3), 8.0–7.91 (m, 7H), 3.66 (s, 8H). 13C-NMR
(DMSO-d6, 100°C) (ppm), 162.9, 154.9, 139.8, 137.7, 130.9, 127.1, 125.9, 118.9, 49.2. MS
m/e 367 (M+).
The free base 7 was suspended in 10–15 ml anhydrous ethanol saturated with HCl and
warmed at gentle reflux for 4 h. The excess ethanol was then removed under reduced
pressure and the resultant solid was triturated with anhydrous ether. The solid was collected
by filtration, washed with ether and dried in vacuo at 80°C for 24 h to yield 0.3 g (36%) mp
> 360°C. Anal calc for: C23H21N5·2HCl·H2O: C, 60.26; H, 5.50; N, 15.28. Found: C, 60.29;
H, 5.51; N, 15.30. IR (KBr) (cm–1) 3412, 3128, 2969, 1618, 1452, 1366, 1280, 1032, 861,
811, 739, 666. 1H-NMR (DMSO-d6) (ppm, J values in Hz) 4.05 (s, 8H), 8.14 (t, 1H, J =
5.86), 8.21 (d, 2H, J = 8.30), 8.28 (d, 4H, J = 8.31), 8.50 (d, 4H, J = 8.31), 11.02 (brs,
4H). 13C-NMR (DMSO-d6) (ppm) 44.3, 121.0, 122.6, 127.2, 129.3, 143.6, 154.2, 164.4.
2-[4-(4,5-Dihydro-1H-imidazol-2-yl)phenyl]-6-[3-(4,5-dihydro-1H-imidazol-2-
yl)phenyl]pyridine 8
The bis-cyano compound 5 was reacted with ethylenediamine hydrochloride as described
above to yield 0.3 g (40%) of the free base 8, mp 254–255°C. Anal calc for: C23H21N5·0.25
H2O: C, 74.26; H, 5.69; N, 18.83. Found: C, 74.89; H, 6.01; N, 18.80. 1H-NMR (DMSO-d6,
90°C) (ppm, J values in Hz), 8.6 (dd, 1H, J = 1.5, J = 1.9), 8.3–8.24 (m, 3H), 8.04–7.9 (br,
2H), 3.66 (s, 4H), 3.64 (s, 4H). 13C-NMR (DMSO-d6, 90°C) (ppm), 163.3, 163.0, 155.3,
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154.9, 138.5, 138.1, 131.2, 131.1, 128.4, 128.1, 127.6, 127.3, 126.1, 125.1, 119.1, 49.6,
49.5. MS m/e 367 (M+).
The salt (mp > 360°C) was prepared as described above. Anal calc for: C23H21N5·3HCl: C,
57.93; H, 5.07; N, 14.68. Found: C, 57.65; H, 5.38; N, 14.59. IR (KBr) (Cm–1), 3411, 3189,
3089, 2967, 1617, 1594, 1566, 1372, 1278, 1033, 805, 706. 1H-NMR (DMSO-d6, 90°C)
(ppm, J values in Hz) 11.08 (br, 4H), 8.95 (br, 1H), 8.6 (d, 1H, J = 7.8), 8.49 (d, 2H, 7.8),
8.29–8.06 (m, 6H), 7.79 (dd, 1H, J = 7.8, J = 7.3), 4.06 (s, 4H), 4.04 (s, 4H). 13C-NMR
(DMSO-d6/90°C) (ppm) 164.7, 164.3, 154.2, 153.8, 143.4, 139.3, 138.2, 131.9, 129.1,
128.8, 128.7, 126.8, 126.7, 122.5, 122.1, 120.2, 120.0, 44.0.
2,6-Bis[3-(-4,5-dihydro-1H-imidazol-2-yl)phenyl]pyridine 9
The bis-cyano compound 6 was reacted with ethylenediamine dihydrochloride as described
above to yield 0.25 g (34%) mp 126–127°C. Anal calc for: C23H21N5.0.25 H1O: C, 74.26;
H, 5.69; N, 18.83. Found: C, 74.01; H, 5.88; N, 18.62. IR (KBr) (cm–1) 3216, 2930, 2865,
1611, 1570, 1492. 1H-NMR (DMSO-d6, 100°C) (ppm. J values in Hz) 8.58 (t, 2H, J = 1.5),
8.29 (dd, 2H, J = 7.8, J = 1.0), 8.02 (m, 3H), 7.93 (dd, 2H, J = 6.35, J = 1.0), 7.58 (dd, 2H, J
= 8.3, J = 7.81), 3.66 (s, 8H). 13C-NMR (DMSO-d6, 60°C) (ppm), 163.3, 155.3, 138.5,
138.1, 131.0, 128.2, 127.6, 125.1, 119.0, 49.5. MS m/e 367 (M+).
The salt was prepared as described above to yield 0.2 g (35%), mp 330°C (dec). Anal calc
for: C23H21N5·3HCl: C, 57.93; H, 5.07; N, 14.68. Found: C, 57.65; H, 5.38; N, 14.59. IR
(KBr) (cm–1) 3397, 3103, 3000, 1618, 1570, 1366, 1285, 1035, 796, 704. 1H-NMR (DMSO-
d6/l00°C) (ppm, J values in Hz) 9.05 (s, 2H), 8.61 (d, 2H. J = 7.8), 8.18–1.10 (m, 5H), 7.79
(t. 2H, J = 7.8), 4.07 (s, 8H). 13C-NMR (DMSO-d6, 100°C) (ppm) 164.7, 154.1, 139.2,
132.1, 129.2, 128.6, 126.9, 122.5, 119.7, 44.0.
2,5-Bis-4-(4,5-dihydro-1H-imidazol-2-yl)phenyl)pyridine 13
The bis-cyano compound 12 was reacted with ethylenediamine hydrochloride as described
above to yield 0.33 g (45%) of the free base 13, mp > 360°C. Anal calc for: C23H21N5: C,
75.17; H, 5.76; N, 19.06. Found: C. 75.09; H, 5.80; N, 18.99. IR (KBr) (cm–1) 3196, 2924,
1610, 1600, 1521, 1490. 1H-NMR (DMSO-d6, 110°C) (ppm, J values in Hz) 9.03 (d, 1H, J
= 1.85), 8.20 (dd, 1H, J = 1.85, J = 8.49), 8.15 (d, 2H, J = 8.3). 8.05 (d, 1H, J = 8.49), 7.97
(d, 2H, J = 8.3), 7.94 (d, 2H, J = 8.3), 7.81 (d, 2H, J = 8.3), 3.67 (s, 8H). 13C-NMR (not
obtained; not soluble). MS m/e 367 (M+).
The salt (mp > 360°C) was prepared as described above. Anal calc for C23H21N5: C, 75.17;
H, 5.76; N, 19.06. Found: C, 75.09; H, 5.80; N, 18.99. IR (KBr) 3390, 3117, 2965, 1611,
1590, 1360, 1273, 1028, 831, 739. 1H-NMR (DMSO-d6/110°C) (ppm, J values in Hz) 9.03
(d, 1H, J = 1.9), 8.20 (dd, 1H, J = 1.9, J = 8.5), 8.15 (d, 2H, J = 8.3), 8.05 (d, 1H, J = 8.5),
7.49 (d, 2H, J = 8.3), 7.94 (d, 2H, J = 8.3), 7.81 (d, 2H, J = 8.3), 3.67 (s, 8H). 13C-NMR (not
obtained: not soluble).
3,5-Bis[4-(4,5-dihydro-1H-imidazol-2-yl)phenylpyridine 18
The bis-cyano compound 17 was reacted with ethylenediamine hydrochloride as described
above to yield 0.35 g (47%) of the free base 18, mp 326–327°C. Anal calc for: C23H21N5: C,
75.17; H, 5.76: N, 19.06. Found: C, 75.08; H, 5.78; N, 19.03. IR (KBr) (cm–1) 3168, 2936,
2863, 1617, 1600, 1552. 1H-NMR (DMSO-d6, 95°C) (ppm, J values in Hz), 8.91 (d, 2H, J =
1.8). 8.35 (dd, 1H, J = 1.83, J = 2.4), 7.96 (d, 4H, J = 7.94), 7.88 (d. 4H, J = 8.55), 3.65 (s,
8H). 13C-NMR (DMSO-d6, 95°C) (ppm) 162.9, 146.4. 138.1, 134.7, 131.6, 130.2, 127.4,
126.4, 49.3. MS m/e 367 (M+).
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The salt (mp > 360°C) was prepared as described above. Anal calc for C23H21N5: C, 75.17;
H, 5.76; N, 19.06. Found: C, 75.08; H, 5.78; N, 19.03. IR (KBr) (cm–1) 3411, 3111, 2967,
1617, 1600, 1511, 1394, 1366, 1278, 1027, 839, 661. 1H-NMR (DMSO-d6/95°C) (ppm, J
values in Hz) 8.91 (d, 2H. J = 1.83). 8.35 (t, 1H, J = 1.83,.1 = 2.44). 7.96 (d, 4H, J = 7.9),
7.88 (d, 4H, J = 8.5), 3.65 (s, 8H). 13C-NMR (DMSO-d6/95°C) (ppm) 162.9, 146.4, 138.1,
134.7, 131.6, 130.2, 127.4, 126.4, 49.3.
2-Phenyl-6-[4-bromophenyl]pyridine
A mixture of α-[N-pyridinium]acetophenone bromide (5.56 g, 0.02 mol), β-(N,N-
dimethylamino)-4-bromopropiophenone hydrochloride (5.8 g, 0.02 mol). ammonium acetate
(15.4 g, 0.25 mol) in 35 ml acetic acid and 10.0 ml acetic anhydride were heated at reflux
for 2 h. On pouring into ice-water, a brown solid formed, which after recrystallization from
ethanol/ether (1:3) yielded 3.2 g (53%) of white solid; mp 113–114°C. IR (KBr) 3064, 1598,
1573, 1446, 1170, 1070, 1007, 807, 696 cm–1. 1H-NMR (DMSO-d6) (ppm, J values in Hz)
8.19 (d, 1H, J = 1.5), 8.14 (d, 2H, J = 8.8), 7.93–7.89 (m, 3H). 7.69 (d, 2H, J = 8.3), 7.54–
7.45 (m, 3H). 13C-NMR (DMSO-d6) (ppm) 155.6, 154.3, 138.4, 138.2, 137.7, 131.5, 129.0,
128.6, 128.4, 126.5, 122.6, 119.0, 118.6. MS m/e 310 (M+).
2-Phenyl-6-[4-cyanophenyl]pyridine
The monobromo compound (3.1 g, 0.01 mol) above and copper(I) cyanide (1.8 g, 0.02 mol)
in 20 ml dry DMF was heated at reflux for 15 h. Work-up as described for 4 gave, after
recrystallization from CHCl3/ether (1:3), 1.8 g (69%) of off-white solid; mp 108–109°C. IR
(KBr) 3070, 223, 1605, 1585, 1563, 1446, 1270, 1017, 987, 812, 760 cm–1. 1H-NMR
(DMSO-d6) (ppm, J values in Hz) 8.33 (d, 2H, J = 8.8), 8.16 (d, 2H, J = 8.3), 7.9–7.87 (m,
5H), 7.53–7.44 (m, 3H). 13C-NMR (DMSO-d6) (ppm) 155.8, 153.4, 142.6, 138.1, 138.0,
132.2, 128.8, 128.3, 127.0, 126.3, 119.5, 119.2, 118.3, 111.3. MS (m/e) 256 (M+).
2-Phenyl-6-[4-(4,5-dihydro-1H-imidazol-2-yl)phenyl]pyridine 19
The monocyano compound above (0.62 g, 0.002 mol) was added to molten ethylenediamine
hydrochloride (0.7 g, 0.002 mol) and the temperature was maintained at ca 300°C for 10
min. The mixture was allowed to cool and the solid was dissolved in hot water, filtered, and
the aqueous solution was concentrated under a stream of nitrogen. The solid thus obtained
was filtered and redissolved in 10 ml water and made basic with 2 M NaOH, the resulting
solid was washed with water, dried and recrystallized from ethanol to yield 0.37 g (S7%) of
white solid, mp 198–199°C, IR (KBr) 3178, 3034, 2929, 2861, 1604, 1563, 1515, 1422,
1379, 1272, 980, 828, 740 cm–1. 1H-NMR (DMSO-d6) (ppm, J values in Hz) 8.96 (d, 1H, J
= 4.89), 8.53 (br, 2H), 8.39 (d, 2H, J = 8.3), 8.04–8.01 (m, 3H), 7.56–7.55 (br, m, 4H), 3.67
(s, 4H). 13C-NMR (DMSO-d6) (ppm) 163.3, 163.1, 158.7, 139.8, 139.7, 132.6, 130.8, 128.6,
127.7, 126.9, 115.2, 49.4. Mass m/e 299 (M+).
The free base (0.28 g, 0.001 mol) dissolved in 10 ml absolute ethanol and treated with 10 ml
ethanol saturated with HCl was heated at ca 60°C for 10 min. The solution was diluted with
50 ml dry ether and the resulting off-white solid was filtered, dried in vacuo at 75°C for 12
h, yield 0.3 g (84%), mp > 330°C. Anal calc for: C20H17N3·2HCl: C, 64.52; H, 5.14; N,
11.28. Found: C, 64.48; H, 5.30; N, 11.21. IR (KBr) 3065, 2991, 1611, 1567, 1469, 1384,
1280, 1029, 828, 739, 675 cm–1. 1H-NMR (DMSO-d6) (ppm, J values in Hz) 11.23 (s, 2H),
9.0 (d, 1H, J = 5.4), 8.56–8.49 (m, 4H), 8.36 (d, 2H, J = 8.8), 8.12 (d, 1H, 5.4). 7.56–7.53
(m, 4H), 6.2 (brs, 1H), 4.02 (s, 4H). 13C-NMR (DMSO-dh) (ppm) 163.9, 163.4, 161.1,
159.0, 141.5, 141.3, 136.9,130.9, 129.4, 128.6, 127.8, 127.5, 124.1, 115.7, 44.3.
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a) Br2/HOAc, pyridine; b) H2CO, HN(CH3)2, HCl, EtOH; c) NH4OAc, Ac2O; d) CuCN,
DMF; e) NH2CH2CH2NH3+, 300°C.
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a) DIBAL, morpholine; b) t-Bu-N = CH2, see text; c) CuCN, DMF; d) ,
300°C.
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a) PCl5; b) KOH, EtOH; c) Cu(OAc)2, MeOH, pyridine; d) 145°C, C6H5CH2CH2NH2; e)
CuCN, DMF; f) , 300°C.
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